Longboard Pharmaceuticals (LBPH) Short Interest Ratio & Short Volume → Everybody laughed when he recommended Netflix (From Stansberry Research) (Ad) Free LBPH Stock Alerts $20.40 -0.44 (-2.11%) (As of 05/21/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Longboard Pharmaceuticals Short Interest DataCurrent Short Interest4,330,000 sharesPrevious Short Interest4,920,000 sharesChange Vs. Previous Month-11.99%Dollar Volume Sold Short$92.23 millionShort Interest Ratio8.6 Days to CoverLast Record DateApril 30, 2024Outstanding Shares38,880,000 sharesFloat Size33,260,000 sharesShort Percent of Float13.02%Today's Trading Volume197,623 sharesAverage Trading Volume1,085,522 sharesToday's Volume Vs. Average18% Short Selling Longboard Pharmaceuticals ? Sign up to receive the latest short interest report for Longboard Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLBPH Short Interest Over TimeLBPH Days to Cover Over TimeLBPH Percentage of Float Shorted Over Time Ad Crypto 101 Media[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. Longboard Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20244,330,000 shares $92.23 million -12.0%13.0%8.6 $21.30 4/15/20244,920,000 shares $89.79 million -0.6%14.8%8.3 $18.25 3/31/20244,950,000 shares $106.92 million +32.4%14.9%7.7 $21.60 3/15/20243,740,000 shares $72.26 million +17.2%11.3%2.6 $19.32 2/29/20243,190,000 shares $70.75 million +0.3%9.9%2.3 $22.18 2/15/20243,180,000 shares $66.27 million +30.3%9.8%2.4 $20.84 Get the Latest News and Ratings for LBPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Longboard Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/20242,440,000 shares $51.83 million +43.5%7.9%2 $21.24 1/15/20241,700,000 shares $39.87 million +138.8%9.9%1.6 $23.45 12/31/2023711,800 shares $4.29 million +22.5%4.2%0.7 $6.03 12/15/2023581,200 shares $2.92 million +13.3%3.4%7.7 $5.02 11/30/2023512,800 shares $1.93 million +8.1%2.9%9.7 $3.76 11/15/2023474,400 shares $2.32 million -3.0%2.7%10.2 $4.88 10/31/2023488,800 shares $2.65 million -2.0%2.9%10.5 $5.42 10/15/2023498,500 shares $2.51 million -8.7%3.0%8.1 $5.03 9/30/2023546,200 shares $3.04 million -4.1%3.3%8.6 $5.56 9/15/2023569,600 shares $3.55 million -10.1%3.1%8.3 $6.23 8/31/2023633,900 shares $3.67 million -4.0%3.5%5.8 $5.79 8/15/2023660,300 shares $4.26 million +0.4%3.6%5.9 $6.45 7/31/2023657,800 shares $4.74 million -7.9%4.2%5.3 $7.20 7/15/2023714,400 shares $4.74 million -2.5%5.1%5.7 $6.64 6/30/2023732,800 shares $5.38 million +165.2%5.2%5.4 $7.34 6/15/2023276,300 shares $2.14 million +36.5%2.0%2.1 $7.76 5/31/2023202,400 shares $1.40 million +149.9%1.4%2.2 $6.93 5/15/202381,000 shares $718,470.00 +352.5%0.6%1 $8.87 4/30/202317,900 shares $148,212.00 +23.5%0.1%0.3 $8.28 4/15/202314,500 shares $88,160.00 +93.3%0.1%0.3 $6.08 3/31/20237,500 shares $30,075.00 -27.2%0.1%0.2 $4.01 3/15/202310,300 shares $49,337.00 -16.3%0.1%0.4 $4.79 2/28/202312,300 shares $62,238.00 -9.6%0.1%0.5 $5.06 2/15/202313,600 shares $67,864.00 -24.9%0.2%0.5 $4.99 1/31/202318,100 shares $77,106.00 +1.1%0.2%0.8 $4.26 1/15/202317,900 shares $105,699.50 +25.2%0.2%0.8 $5.91 12/30/202214,300 shares $46,618.00 -18.3%0.2%0.7 $3.26 12/15/202217,500 shares $70,350.00 -45.1%0.2%0.9 $4.02 11/30/202231,900 shares $171,303.00 -33.5%0.4%1.5 $5.37 11/15/202248,000 shares $227,520.00 +21.5%0.5%2.3 $4.74 10/31/202239,500 shares $146,150.00 -13.6%0.4%1.4 $3.70 10/15/202245,700 shares $150,810.00 -9.5%0.5%2.1 $3.30 9/30/202250,500 shares $187,860.00 +9.3%0.6%2.3 $3.72 9/15/202246,200 shares $198,660.00 +94.1%0.5%2.1 $4.30Elon’s New Device is About to Shock the World (Ad)Using this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. 8/31/202223,800 shares $79,730.00 -24.2%0.3%1.2 $3.35 8/15/202231,400 shares $133,921.00 -34.3%0.3%2 $4.27 7/31/202247,800 shares $160,608.00 +9.9%0.5%6.7 $3.36 7/15/202243,500 shares $143,115.00 -11.6%0.5%6.2 $3.29 6/30/202249,200 shares $152,028.00 -12.1%0.5%5.2 $3.09 6/15/202256,000 shares $235,200.00 -18.4%0.6%6.4 $4.20 5/31/202268,600 shares $352,604.00 +11.5%0.8%6.5 $5.14 5/15/202261,500 shares $276,750.00 -16.7%0.7%5.4 $4.50 4/30/202273,800 shares $356,653.26 -14.2%0.8%5.3 $4.83 4/15/202286,000 shares $429,140.00 -3.2%0.9%5.5 $4.99 3/31/202288,800 shares $474,192.00 +8.3%1.0%4.6 $5.34 3/15/202282,000 shares $415,740.00 -10.6%0.9%2.5 $5.07 2/28/202291,700 shares $420,903.00 -4.1%1.0%2.6 $4.59 2/15/202295,600 shares $477,044.00 +21.6%1.0%2.8 $4.99 1/31/202278,600 shares $330,120.00 -22.8%0.9%2.2 $4.20 1/15/2022101,800 shares $433,668.00 -4.9%1.1%2.4 $4.26 12/31/2021107,000 shares $522,160.00 +47.4%1.2%2.4 $4.88 12/15/202172,600 shares $431,970.00 +9.7%0.8%2.1 $5.95 11/30/202166,200 shares $370,389.00 -3.8%0.7%2.3 $5.60 11/15/202168,800 shares $427,248.00 +44.5%0.8%2.3 $6.21 10/29/202147,600 shares $354,620.00 -25.0%0.5%1.5 $7.45 10/15/202163,500 shares $562,610.00 -12.5%0.7%2.3 $8.86 9/30/202172,600 shares $642,510.00 -9.3%0.8%1.4 $8.85 9/15/202180,000 shares $736,000.00 -9.8%0.9%1.5 $9.20 8/31/202188,700 shares $832,006.00 +25.3%1.0%1.5 $9.38 8/13/202170,800 shares $652,776.00 No Change0.8%1.1 $9.22 LBPH Short Interest - Frequently Asked Questions What is Longboard Pharmaceuticals' current short interest? Short interest is the volume of Longboard Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 4,330,000 shares of LBPH short. 13.02% of Longboard Pharmaceuticals' shares are currently sold short. Learn More on Longboard Pharmaceuticals' current short interest. What is a good short interest ratio for Longboard Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LBPH shares currently have a short interest ratio of 9.0. Learn More on Longboard Pharmaceuticals's short interest ratio. What is a good short interest percentage for Longboard Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.02% of Longboard Pharmaceuticals' floating shares are currently sold short. Is Longboard Pharmaceuticals' short interest increasing or decreasing? Longboard Pharmaceuticals saw a decline in short interest during the month of April. As of April 30th, there was short interest totaling 4,330,000 shares, a decline of 12.0% from the previous total of 4,920,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Longboard Pharmaceuticals' float size? Longboard Pharmaceuticals currently has issued a total of 38,880,000 shares. Some of Longboard Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Longboard Pharmaceuticals currently has a public float of 33,260,000 shares. How does Longboard Pharmaceuticals' short interest compare to its competitors? 13.02% of Longboard Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Longboard Pharmaceuticals: ALX Oncology Holdings Inc. (11.46%), Disc Medicine, Inc. (12.97%), Praxis Precision Medicines, Inc. (5.06%), Evolus, Inc. (9.69%), Arcturus Therapeutics Holdings Inc. (20.02%), Tango Therapeutics, Inc. (19.84%), Dianthus Therapeutics, Inc. (9.95%), Zentalis Pharmaceuticals, Inc. (24.64%), PureTech Health plc (0.02%), Aurinia Pharmaceuticals Inc. (8.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Longboard Pharmaceuticals stock? Short selling LBPH is an investing strategy that aims to generate trading profit from Longboard Pharmaceuticals as its price is falling. LBPH shares are trading down $0.44 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Longboard Pharmaceuticals? A short squeeze for Longboard Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LBPH, which in turn drives the price of the stock up even further. How often is Longboard Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LBPH, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: AUPH Short Interest PRTC Short Interest NRIX Short Interest ARCT Short Interest IRON Short Interest IMNM Short Interest TNGX Short Interest PRAX Short Interest ZNTL Short Interest PAHC Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LBPH) was last updated on 5/22/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersWarren Buffett's "mystery stock"Stansberry ResearchNew Options need New Trading StrategiesNetpicksObama’s Forever Term [exposed]Porter & CompanyTrump’s second term “playbook” leaked?Paradigm PressYou won’t see these trades on TVProsper Trading AcademyThis could mean the end of the U.S dollar…Colonial MetalsMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlace